Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11359025 Anti-IL1-RAP antibodies

Patent 11359025 was granted and assigned to Cantargia on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113590250

Patent Inventor Names

Jagath R. Junutula0

Leonard G. Presta0

Ying Ping Jiang0

Date of Patent

June 14, 2022

Patent Application Number

163421760

Date Filed

October 16, 2017

Patent Citations

‌

US Patent 10005841 Method of treating a solid tumor with IL1RAP antibodies

‌

US Patent 10100119 Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer

‌

US Patent 10287357 Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies

‌

US Patent 10562971 Method of detection of IL1RAP on cells expressing the protein

‌

US Patent 10005842 Method of treatment for leukemia using an anti-IL1RAP antibody

Patent Primary Examiner

‌

Brian Gangle

Provided herein are antibodies specific for Interleukin-1 receptor accessory protein (IL1-RAP).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11359025 Anti-IL1-RAP antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API